Boucai L, Zafereo M, Cabanillas ME (2024) Thyroid Cancer: Rev JAMA 331(5):425–435

CAS  Google Scholar 

Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, Vaccarella S (2022) The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol 10(4):264–272

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249

Article  PubMed  Google Scholar 

Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simoes M, Tallini G et al (2022) Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol 33(1):27–63

Article  PubMed  Google Scholar 

Ywata de Carvalho A, Kohler HF, Gomes CC, Vartanian JG, Kowalski LP (2021) Predictive factors for recurrence of papillary thyroid carcinoma: analysis of 4,085 patients. Acta Otorhinolaryngol Ital 41(3):236–242

Article  PubMed  PubMed Central  Google Scholar 

Coca-Pelaz A, Shah JP, Hernandez-Prera JC, Ghossein RA, Rodrigo JP, Hartl DM, Olsen KD, Shaha AR, Zafereo M, Suarez C et al (2020) Papillary thyroid Cancer-aggressive variants and impact on management: a narrative review. Adv Ther 37(7):3112–3128

Article  PubMed  PubMed Central  Google Scholar 

Nemeth K, Bayraktar R, Ferracin M, Calin GA (2024) Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet 25(3):211–232

Article  CAS  PubMed  Google Scholar 

McCabe EM, Rasmussen TP (2021) lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol 75:38–48

Article  CAS  PubMed  Google Scholar 

Coan M, Haefliger S, Ounzain S, Johnson R (2024) Targeting and engineering long non-coding RNAs for cancer therapy. Nat Rev Genet 25(8):578–595

Article  CAS  PubMed  Google Scholar 

Fine DA, Rozenblatt-Rosen O, Padi M, Korkhin A, James RL, Adelmant G, Yoon R, Guo L, Berrios C, Zhang Y et al (2012) Identification of FAM111A as an SV40 host range restriction and adenovirus helper factor. PLoS Pathog 8(10):e1002949

Article  CAS  PubMed  PubMed Central  Google Scholar 

Unger S, Gorna MW, Le Bechec A, Do Vale-Pereira S, Bedeschi MF, Geiberger S, Grigelioniene G, Horemuzova E, Lalatta F, Lausch E et al (2013) FAM111A mutations result in hypoparathyroidism and impaired skeletal development. Am J Hum Genet 92(6):990–995

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu H, Lin L, Zhang Z, Zhang H, Hu H (2020) Targeting NF-kappaB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther 5(1):209

Article  CAS  PubMed  PubMed Central  Google Scholar 

Betzler AC, Theodoraki MN, Schuler PJ, Doscher J, Laban S, Hoffmann TK, Brunner C (2020) NF-kappaB and its role in Checkpoint Control. Int J Mol Sci 21(11)

Eluard B, Thieblemont C, Baud V (2020) NF-kappaB in the New Era of Cancer Therapy. Trends Cancer 6(8):677–687

Article  CAS  PubMed  Google Scholar 

Mirzaei S, Saghari S, Bassiri F, Raesi R, Zarrabi A, Hushmandi K, Sethi G, Tergaonkar V (2022) NF-kappaB as a regulator of cancer metastasis and therapy response: a focus on epithelial-mesenchymal transition. J Cell Physiol 237(7):2770–2795

Article  CAS  PubMed  Google Scholar 

Oh A, Pardo M, Rodriguez A, Yu C, Nguyen L, Liang O, Chorzalska A, Dubielecka PM (2023) NF-kappaB signaling in neoplastic transition from epithelial to mesenchymal phenotype. Cell Commun Signal 21(1):291

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pacifico F, Leonardi A (2010) Role of NF-kappaB in thyroid cancer. Mol Cell Endocrinol 321(1):29–35

Article  CAS  PubMed  Google Scholar 

Crescenzi E, Leonardi A, Pacifico F (2024) NF-kappaB in thyroid Cancer: an update. Int J Mol Sci 25(21)

Palona I, Namba H, Mitsutake N, Starenki D, Podtcheko A, Sedliarou I, Ohtsuru A, Saenko V, Nagayama Y, Umezawa K et al (2006) BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation. Endocrinology 147(12):5699–5707

Article  CAS  PubMed  Google Scholar 

Faria M, Matos P, Pereira T, Cabrera R, Cardoso BA, Bugalho MJ, Silva AL (2017) RAC1b overexpression stimulates proliferation and NF-kB-mediated anti-apoptotic signaling in thyroid cancer cells. PLoS ONE 12(2):e0172689

Article  PubMed  PubMed Central  Google Scholar 

Cancer Genome Atlas Research N (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159(3):676–690

Article  Google Scholar 

Su Y, Xu B, Li J, Shen Q, Lei Z, Ma M, Zhang F, Hu T (2023) Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer. Ann Med 55(1):1298–1316

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee KS, Park H (2022) Machine learning on thyroid disease: a review. Front Biosci (Landmark Ed) 27(3):101

Article  CAS  PubMed  Google Scholar 

Guo F, Fu Q, Wang Y, Sui G (2019) Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis. J Cell Mol Med 23(9):5907–5919

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV et al (2018) An Integrated TCGA Pan-cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell 173(2):400–416 e411

Article  CAS  PubMed  PubMed Central  Google Scholar 

Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252–7259

Article  CAS  PubMed  Google Scholar 

Wang L, Park HJ, Dasari S, Wang S, Kocher JP, Li W (2013) CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model. Nucleic Acids Res 41(6):e74

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kang YJ, Yang DC, Kong L, Hou M, Meng YQ, Wei L, Gao G (2017) CPC2: a fast and accurate coding potential calculator based on sequence intrinsic features. Nucleic Acids Res 45(W1):W12–W16

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhan A, Soleimani M, Mandal SS (2017) Long noncoding RNA and Cancer: a New Paradigm. Cancer Res 77(15):3965–3981

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pu J, Xu Z, Huang Y, Nian J, Yang M, Fang Q, Wei Q, Huang Z, Liu G, Wang J et al (2023) N(6) -methyladenosine-modified FAM111A-DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111A. Cancer Sci 114(9):3649–3665

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Jin T, Shen H, Yan J, Guan M, Jin X (2019) Identification of long non-coding RNA expression profiles and co-expression genes in thyroid carcinoma based on the Cancer Genome Atlas (TCGA) database. Med Sci Monit 25:9752–9769

Article  CAS  PubMed  PubMed Central  Google Scholar